Abstract
The pathology associated with viral infections as well as the attempts to prevent them are closely dependent on the biology of virus-host interactions. A unique feature of herpes simplex viruses 1 and 2 (HSV-1 and HSV-2) is that, in the course of the primary infection, the viruses multiply at the portal of entry, infect sensory or autonomic nerve endings, ascend through the axon to the neuronal nucleus and establish a latent infection that is shielded from the immune defenses of the host. In a significant fraction of infected individuals, the latent viruses are reactivated by a variety of stimuli and cause clinically discernible lesions. Indeed, most of the morbidity associated with HSV is the result of such recrudescences. Prevention of morbidity caused by HSV, unlike that caused by other viruses, requires blocking the establishment of latency. Inasmuch as establishment of latency results from multiplication at the portal of entry, such prevention requires a state of immunity induced by immunization that is potent enough to preclude this initial multiplication, a very tall order. On the grounds that inactivated or subunit vaccines are not likely to generate both the required duration and level of immunity, we chose to construct a live attenuated HSV vaccine by the techniques of genetic engineering described in detail elsewhere (Roizman and Jenkins, 1985).
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Arsenakis M, Poffenberger KL and Roizman B. Novel herpes simplex virus genomes : Construction and application. In : Gallo RC, Haseltine W, Klein G and Zur Hausen H, eds. : “Viruses and human cancer”. Proceedings of the UCLA Symposia on Molecular and Cellular Biology, New series. 1987. Vol 43, pp 427–441. Alan R. Liss, Inc., New york.
Buchman TG, Roizman B, Adams G and Stover H. Restriction endonuclease fingerprinting of herpes simplex virus DNA: A novel epidemiological tool applied to a nosocomial outbreak. J. Infect, Dis. 1978 ; 138 : 488–498.
Centifano-Fitzgerald YM, Yamaguchi T, Kaufman M, Tognon M, Roizman B. Ocular disease pattern induced by herpes simplex virus is genetically determined by a specific region of viral DNA. J. Exp. Med. 1982;155:475
Meignier B, Longnecker R and Roizman B. In vivo behavior of genetically engineered herpes simplex viruses R7017 and R7020. I. Construction and evaluation in rodent animal models. J. infect. Dis. 1988. accepted for publication.
Roizman B, Meignier B, Norrild B, Wagner JL. Bioengineering of herpes simplex virus variants for potential use as live vaccines. 1984. In : “Modern approaches to vaccines. Molecular and chemical basis of virus virulence and immunogenicity”. Edited by RM Chanock and RA Lerner. Cold Spring Harbor Laboratory. pp 274–281,1984
Roizman B and Jenkins FJ. Genetic engineering of novel genomes of large PNA viruses. Science 1985;229:1208–1214.
Shih MF, Arsenakis M, Tiollais P and Roizman B. Expression of Hepatitis B virus S gene by Herpes simplex virus 1 vectors carrying a and β regulated gene chimeras. Proc. Nat. Acad. Sci. (USA) 1984;81:5867–5870.
Tevethia MJ. Transforming potential of herpes simplex viruses and human cytomegalovirus. In : B Roizman and C Lopez, eds, The herpesviruses, 1985, Vol 3, 257–313. Plenum Press, New york, N.Y.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1989 Plenum Press, New York
About this paper
Cite this paper
Meignier, B., Roizman, B. (1989). Genetic Engineering and Properties of Novel Herpes Simplex Viruses for Use as Potential Vaccines and as Vectors of Foreign Genes. In: Askonas, B.A., Moss, B., Torrigiani, G., Gorini, S. (eds) The Immune Response to Viral Infections. Advances in Experimental Medicine and Biology, vol 257. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-5712-4_17
Download citation
DOI: https://doi.org/10.1007/978-1-4684-5712-4_17
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-5714-8
Online ISBN: 978-1-4684-5712-4
eBook Packages: Springer Book Archive